Executive Waves Goodbye to More Than 6,000 Shares of Legendary Insurance Stock

John D. McCallion, EVP & Chief Financial Officer of MetLife, Inc. (NYSE:MET), reported a non-discretionary disposition of 6,057 shares on Aug. 31, 2026, according to a recent SEC Form 4 filing.

Transaction summary

Transaction value based on SEC Form 4 weighted average sale price ($95.17); post-transaction value based on Aug. 31, 2026 market close ($95.17).

Key questions

• What was the primary driver behind this disposition of shares?
  The transaction was a non-discretionary event in which the company withheld shares to satisfy tax liabilities arising from the vesting of restricted stock units. This automated execution is a standard component of executive equity compensation and is independent of the insider’s sentiment regarding company valuation.

• What is the insider’s remaining equity exposure following this transaction?
  McCallion continues to hold a direct stake of 269,137 shares, which represents a market value of $25.4 million as of the Sept. 1, 2026, market close. The executive also holds derivative securities.

• How does the insider’s total ownership compare to the company’s capitalization?
  The reported direct position of 269,137 shares accounts for approximately 0.0418% of the company’s total shares outstanding. This transaction occurred as the stock had generated a 17% one-year total return as of the Aug. 31, 2026, transaction date.

Company Overview

Company Snapshot

• MetLife provides a comprehensive suite of insurance products and services, including life insurance, annuities, dental coverage, disability insurance, pet insurance, and asset management solutions across global markets.

• The company generates revenue through premium collections on insurance policies, investment returns on managed assets, and fees for employee benefits administration and financial advisory services.

• MetLife serves a diverse customer base encompassing individual consumers, employers seeking group benefits solutions, and institutional investors requiring annuity and asset management products across more than 40 countries.

MetLife operates as a leading global financial services provider with approximately 46,000 employees and a diversified business model spanning five primary geographic and operational divisions: the United States, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings. The company maintains a competitive advantage through its extensive distribution network, strong brand recognition, and integrated product ecosystem that addresses comprehensive insurance and retirement planning needs for both individual and institutional clients worldwide.

What this transaction means for investors

Retail investors should be careful when reviewing insider transactions, particularly insider sales. While insider buys are typically straightforward, insider sales occur for many reasons, many of which relate to complex wealth management strategies. In turn, retail investors should always return to basics by reviewing a company’s fundamentals to determine whether a stock is suitable for their investment portfolio. With that in mind, let’s have a closer look at MetLife (MET).

To begin, let’s review MetLife’s recent performance relative to the stock market. Since 2021, MET shares have generated a total return of 82%, equating to a compound annual growth rate (CAGR) of 12.7%. That matches the S&P 500, which has delivered an identical 82% total return, with a 12.7% CAGR over the same period.

As for fundamentals, most figures appear quite strong. For example, MetLife’s total revenue has increased from $63.5 billion in 2023 to nearly $79.6 billion now. Similarly, free cash flow has surged from under $10.0 billion in 2023 to more than $16.5 billion today.

Yet, not all of the figures are so strong. Net income, for instance, has moderated in recent years, dropping from just under $8.0 billion in 2022 to only $3.7 billion now. Likewise, the operating margin has dropped from a five-year high of 15.1% in 2022 to 7.7%. Part of the reason is that MetLife has altered its product mix, incorporating lower-margin corporate pension plans that have bolstered its total revenue while lowering its profitability.

All in all, MetLife remains a solid insurance stock. Shares have delivered market-matching returns, and many of its key metrics remain solid. With a price-to-earnings (P/E) multiple of 18x, many value-oriented investors would be wise to keep an eye on the stock.

Should you buy stock in MetLife right now?

Before you buy stock in MetLife, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and MetLife wasn’t one of them. The 10 stocks that made the cut are built for long-term growth and could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $414,015!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,385,459!*

That performance is why people listen. With a track record of beating the S&P 500 by 4x, Stock Advisor offers a distinct advantage. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built for the long haul.

See the 10 stocks »

*Stock Advisor returns as of September 9, 2026.

Jake Lerch has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Executive Waves Goodbye to More Than 6,000 Shares of Legendary Insurance Stock was originally published by The Motley Fool